The 11th European Association of Dermato Oncology (EADO) Congress & 8th World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers took place in Marseille, France, 28-31 October 2015. A Rigvir virotherapy retrospective clinical study was presented during the poster sessions. The effectiveness of Rigvir in sub-stage IA-IIC melanoma patients was determined. The results indicate that the patients treated with Rigvir had a 4.39-6.57-fold lower mortality than those under observation. The full details of the study are published in the 2015 October issue of Melanoma Research.






Address
Jumeirah Lake Towers
Swiss Tower, office 204
P.O. Box 309073, Dubai, UAE

Phone
+ 44 20 38 684 002 (UK, London)
+ 1 646 88 33 419 (USA, New York)
+ 371 67 229 599 (Latvia)


© 2024 International Virotherapy Center Limited. All Rights Reserved